|
Volumn 41, Issue 4, 2006, Pages 388-389
|
Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis [1]
a a a a
a
KEIO UNIVERSITY
(Japan)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
GAMMA GLUTAMYLTRANSFERASE;
MESALAZINE;
PREDNISOLONE;
SALAZOSULFAPYRIDINE;
URSODEOXYCHOLIC ACID;
ABDOMINAL PAIN;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
CHRONIC DIARRHEA;
CHRONIC LIVER DISEASE;
COLITIS;
COLONOSCOPY;
DISEASE ASSOCIATION;
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;
ENTERITIS;
EXTRAHEPATIC BILE DUCT OBSTRUCTION;
GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL;
HEMATOCHEZIA;
HOSPITAL ADMISSION;
HUMAN;
LETTER;
LIVER BIOPSY;
PRIMARY SCLEROSING CHOLANGITIS;
PRIORITY JOURNAL;
REMISSION;
ULCERATIVE COLITIS;
ADOLESCENT;
BIOPSY;
CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE;
CHOLANGITIS, SCLEROSING;
GASTROINTESTINAL AGENTS;
HUMANS;
LIVER;
MALE;
SULFASALAZINE;
|
EID: 33744801168
PISSN: 09441174
EISSN: 14355922
Source Type: Journal
DOI: 10.1007/s00535-005-1758-x Document Type: Letter |
Times cited : (17)
|
References (6)
|